Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen has recently been a trending stock, with shares down 7.8% over the past month compared to the S&P 500's +0.8% gain. The biotech company shows solid fundamentals with consistent earnings and revenue beat history, but the Zacks Rank #3 (Hold) rating suggests it may perform in line with the broader market in the near term. Current year earnings are expected to grow 5% with revenue growth of 5.6%, while the stock trades at par with peers based on valuation metrics.